MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1167.99%
Quick Ratio
1167.99%
Cash Ratio
343.31%
Debt to Asset Ratio
8.07%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability, non-c...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
60,034
48,318
44,063
26,818
Short-term investments
140,759
163,146
105,137
49,244
Prepaid expenses and other current assets
3,453
4,391
4,278
5,879
Total current assets
204,246
215,855
153,478
81,941
Operating lease right-of-use assets, net
7,568
7,930
1,469
160
Property and equipment, gross
3,241
-
2,553
-
Less accumulated depreciation and amortization
1,591
-
1,559
-
Property and equipment, net
1,650
1,640
994
970
Long-term investments
87,214
95,548
67,489
-
Restricted cash
1,203
1,409
1,415
1,412
Other non-current assets
66
73
101
61
Total assets
301,947
322,455
224,946
84,544
Accounts payable
5,044
4,045
7,756
3,576
Accrued liabilities
10,688
4,734
9,547
6,309
Operating lease liability, current portion
1,237
1,253
242
160
Other current liabilities
518
571
364
371
Total current liabilities
17,487
10,603
17,909
10,416
Operating lease liability, non-current portion
6,440
6,768
1,290
-
Other non-current liabilities
-
-
-
261
Financing lease liability
434
529
181
-
Total liabilities
24,361
17,900
19,380
10,677
Convertible preferred stock 0.0001 par value - 157,657,729 shares authorized at september 30, 2025 and december 31, 2024, respectively, 157,657,729 and 116,716,142 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively (liquidation preference 275,611 and 210,328 at september 30, 2025 and december 31, 2024, respectively)
-
-
-
257,004
Common stock, par value 0.0001 - 500,000,000 shares authorized at june 30, 2026 and december 31, 2025, respectively 36,281,767 and 31,524,093 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
4
4
3
-
Additional paid-in capital
552,591
547,314
426,652
9,679
Accumulated deficit
-275,009
-242,763
-221,089
-192,816
Total stockholders' equity
277,586
304,555
205,566
-183,137
Total liabilities and stockholders' equity
301,947
322,455
224,946
84,544
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$140,759K Cash and cashequivalents$60,034K Prepaid expenses andother current assets$3,453K Property and equipment,gross$3,241K Total current assets$204,246K Long-term investments$87,214K Operating leaseright-of-use assets, net$7,568K Property and equipment,net$1,650K Restricted cash$1,203K Other non-currentassets$66K Less accumulateddepreciation and...$1,591K Total assets$301,947K Total liabilities andstockholders' equity$301,947K Total stockholders'equity$277,586K Total liabilities$24,361K Accumulated deficit-$275,009K Additional paid-in capital$552,591K Total currentliabilities$17,487K Operating leaseliability, non-current...$6,440K Financing lease liability$434K Common stock, par value0.0001 - 500,000,000...$4K Accrued liabilities$10,688K Accounts payable$5,044K Operating leaseliability, current portion$1,237K Other currentliabilities$518K

Evommune, Inc. (EVMN)

Evommune, Inc. (EVMN)